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Περίληψη 
 
Υπό το πρίσμα της διαρκούς βελτίωσης της αποτελεσματικότητας της βέλτιστης φαρμακευτικής 
αντιμετώπισης (ΒΜΤ) στη μείωση του κινδύνου εγκεφαλικού επεισοδίου που σχετίζεται με την 
ασυμπτωματική καρωτιδική στένωση, οι πιο πρόσφατες κατευθυντήριες οδηγίες της American Heart 
Association αναφέρουν ότι η αποτελεσματικότητα της παρέμβασης σε σύγκριση με τη ΒΜΤ για την 
ασυμπτωματική καρωτιδική στένωση δεν έχει εδραιωθεί ικανοποιητικά. Η ανίχνευση της ευάλωτης 
αθηρωματικής πλάκας είναι το «ιερό δισκοπότηρο» στην αναζήτηση των ασθενών που ωφελούνται 
περισσότερο από την παρέμβαση. Ο στόχος αυτής της συστηματικής ανασκόπησης της βιβλιογραφίας 
ήταν η σύνοψη των δημοσιευμένων στοιχείων για τις κλινικές εφαρμογές της τρισδιάστατης 
υπερηχογραφίας του καρωτιδικού διχασμού (3DUS) με απώτερο σκοπό την ανίχνευση του δυναμικού 
αυτής της εξελισσόμενης απεικονιστικής μεθόδου στην αναγνώριση του ευάλωτου καρωτιδικού 
αθηρώματος. Τα δημοσιευμένα στοιχεία δείχνουν ότι η τρισδιάστατη ογκομετρία της ασυμπτωματικής 
καρωτιδικής πλάκας αποτελεί μια αξιόπιστη, επαναλήψιμη και αναπαραγώγιμη, μη-επεμβατική μέθοδο 
της παρακολούθησης της βραχυπρόθεσμης προόδου ή υποστροφής της καρωτιδικής αθηρωμάτωσης 
σαν απάντηση στην εντατικοποίηση της ΒΜΤ όταν τίθεται η ένδειξη παρέμβασης με βάση το βαθμό 
στένωσης. Ειδικά σχεδιασμένες τυχαιοποιημένες μελέτες απαιτούνται για να ελεγχθεί αν η μεταβολή 
του όγκου της αθηρωματικής πλάκας όπως μετράται από τη 3DUS μπορεί να βελτιώσει την ανίχνευση 
των ασυμπτωματικών ασθενών που ωφελούνται από την καρωτιδική παρέμβαση. 
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Abstract 
 
 
 
In light of the improved efficacy of best medical therapy (ΒΜΤ) in reducing stroke risk 
associated with asymptomatic carotid disease the most recent American Heart Association guidelines 
stated that the effectiveness of intervention for asymptomatic carotid disease compared to BMT is not 
well established. Detecting the vulnerability of the carotid atherosclerotic plaque is the “holy grail” to 
the quest of identifying the asymptomatic patients that benefit from intervention. The aim of this 
systematic review of the literature was to summarize published evidence on the clinically relevant 
applications of three dimensional ultrasound (3DUS) in order to detect the potential of this evolving 
imaging field in spotting the vulnerable carotid plaque. Published evidence show that 3DUS plaque 
volumetry is a reliable, repeatable and reproducible, non-invasive technique for monitoring the short-
term progression or regression of asymptomatic carotid atherosclerosis in response to best medical 
treatment enhancement when a stenosis indication for intervention is set. Specially designed randomized 
trials are in order to test whether 3DUS plaque volume change can improve identification of patients 
that benefit the most from asymptomatic carotid intervention. 
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 Introduction 
 
Stroke is a leading cause of death in developed countries. Although the number of deaths from 
stroke is decreasing, it remains a public health problem in the United States, with billions of U.S. dollars 
in direct cost and indirect cost of stroke.1 Carotid artery stenosis represents an important risk factor for 
ischemic stroke, which accounts for nearly 90 percent of all strokes among U.S. men and women. It is 
increasingly prevalent from the fifth decade of life onward2 and patients with vascular disease and 
multiple risk factors (e.g., diabetes, hypertension, hyperlipidemia, and smoking) have a higher 
probability of having asymptomatic carotid stenosis. Since carotid artery atherosclerosis can proceed 
silently and affect approximately 7 percent of women and over 12 percent of men, older than 70 years of 
age3, the first manifestation can be a debilitating or fatal stroke.  
The importance of intervention for symptomatic carotid disease has been established4,5 and has 
been firmly incorporated in guidelines documents6 regardless of the carotid endarterectomy (CEA) 
versus carotid artery stenting (CAS) debate.7 On the other hand, asymptomatic carotid stenosis patients 
have been reported by natural history studies8,9 to be at an increased risk of ipsilateral carotid territory 
ischemic events and this was supported by the 5-year risk of stroke (including perioperative 
stroke/death) in patients randomized to CEA or best medical therapy (BMT) in the Asymptomatic 
Carotid Atherosclerosis Study (ACAS) and the Asymptomatic Carotid Surgery Trial (ACST).10–12 
Consequently, the rationale behind asymptomatic carotid intervention incorporation in consensus 
documents has been the outcome of the “battle” between the stroke risk assumed by the stenosis grade 
versus peri-interventional risk.  
In light of the decreasing risk of stroke for asymptomatic carotid disease patients 13,14 and the 
effectiveness of evolving BMT15 it has become clear that even if CEA/CAS periprocedural risk was 
reduced to 0% the majority (93%) of interventions on ACAS/ACST randomized patients would still be 
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unnecessary in 5 and 10 years respectively.16 Finally, the 2014 American Heart Association (AHA) 
Guidelines recommended that “1. Patients with asymptomatic carotid stenosis  should  be  prescribed 
daily aspirin and a statin. Patients should also be  screened  for  other  treatable  risk  factors  for  stroke,   
and appropriate medical therapies and lifestyle changes  should be instituted (Class I; Level of Evidence 
C). 2. In patients who  are  to  undergo  CEA,  aspirin  is  recommended perioperatively and 
postoperatively unless contraindicated (Class I; Level of Evidence C). 3.  It is reasonable to consider 
performing CEA in asymptomatic patients who have >70% stenosis of the internal carotid artery if the 
risk of perioperative stroke, myocardial infarction (MI), and  death is low (<3%). However, its 
effectiveness compared with contemporary  best  medical  management  alone  is   not well established 
(Class IIa; Level of Evidence A). 4.  It is reasonable to repeat duplex ultrasonography annually  by  a  
qualified  technologist  in  a  certified  laboratory  to  assess  the  progression  or  regression  of  disease 
and  response  to  therapeutic  interventions  in  patients with atherosclerotic stenosis >50% (Class IIa; 
Level of Evidence C). 5.  Prophylactic CAS might be considered in highly selected  patients with 
asymptomatic carotid stenosis (minimum,  60%  by  angiography,  70%  by  validated  Doppler  
ultrasound),  but  its  effectiveness  compared  with  medical   therapy  alone  in  this  situation  is  not  
well  established (Class IIb; Level of Evidence B). 6.   In  asymptomatic  patients  at  high  risk  of  
complications  for  carotid  revascularization  by  either  CEA  or  CAS,  the  effectiveness  of  
revascularization  versus  medical  therapy alone is not well established (Class IIb; Level of Evidence 
B)”.17 
Identification of the vulnerable carotid plaque seems to be the key to asymptomatic carotid 
intervention in terms of decision to intervene and type of intervention. Preoperative plaque vulnerability 
and subsequent perioperative embolic potential18 depend on a panel19 of clinical, imaging, technical and 
biological markers. The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS)20 study  is in the 
process of investigating the effectiveness of panels of markers to detect the patients that benefit the most 
from intervention after reaching the % stenosis threshold. They recently reported that the clinical value 
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of screening for stenosis grade progression simply for selecting patients for carotid procedures is limited 
because of the low frequency of progression and its relatively low associated stroke rate.21 
 Imaging of the carotid plaque in vivo has the leading role amidst the panel of vulnerability 
markers. Various imaging phenotypes have been found to predict long-term  carotid events and thus 
reflect plaque vulnerability (Intima Media Thickness – IMT22, Gray Scale Median - GSM23, 
Juxtaluminal Black Areas - JBA24, Discrete White Areas – DWA20,  Intraplaque Hemorrhage – IPH – on 
Magnetic Resonance Imaging – MRI25–27, fluoro-2-deoxyglucose – FDG - positron emission 
tomography/computed tomography - PET/CT uptake)28. However, these phenotypes’ value as tools for 
evaluating short-term plaque progression is limited22,29. Besides being a vulnerability marker, short-term 
plaque progression can also serve as a means of testing the effect of BMT optimization directly on the 
plaque.  
 
Aim / Objectives 
Even though atherosclerotic plaque is a three dimensional (3D) pathophysiological entity, all of 
the aforementioned Ultrasound (U/S) imaging phenotypes are confined to studying two-dimensional 
(2D) plaque slices. Three dimensional ultrasound (3DUS) has been technically around since 1983 
(phantom apparatus)30 and was first reported to be used in vivo in 1991 by Hennerici et al.31 Subsequent 
technological advances and computer power exponential growth have made it increasingly available for 
research and clinical applications in carotid bifurcation. It’s volumetric and surface reconstruction 
potential seem promising in unmasking previously unavailable features of the vulnerable carotid plaque 
by moving from 2 to 3 dimensional imaging. According their 3D Registration type the main 3DUS 
systems’ realizations are (a) Freehand, where a linear U/S probe is translated manually along or across 
the carotid to produce a series of images; it can be tracked (movement is registered in space by a 
mechanical arm, an electromagnetic sensor32 or other similar application) or untracked (spatial 
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registration is unavailable since probe movement is dependent on operator), (b) Mechanical assemblies, 
where the U/S probe is translated by a linear33/rotational34 stage/motor of given speed and distance/angle 
in order to provide spatial registration and (c) 3D-Real-Time, where the 3rd dimension is provided in 
real-time by an array of perpendicular probes (2D-array35) or relevant technology (UltraFast36 probes). 
The aim of this study was to summarize published evidence on the clinically relevant application 
of 3DUS in order to detect the potential of this evolving imaging field in elucidating the elusive 
vulnerable carotid plaque. By qualitative analysis of caveats, superiority aspects, limitations and 
research gaps of the technique the author will try to point out whether 3DUS can become the “holy 
grail” of asymptomatic carotid intervention.  
 
 
Methods 
The PubMed Database was queried with the search term “carotid[All Fields] AND ("3-d"[All 
Fields] OR "3d"[All Fields] OR "three dimensional"[All Fields] OR "3-dimensional"[All Fields] OR 
"three-dimensional"[All Fields] OR "three dimension"[All Fields] OR "three-dimension"[All Fields] OR 
"three dimensions"[All Fields]) AND ("ultrasonography"[All Fields] OR "ultrasound"[All Fields] OR 
"ultrasonics"[All Fields])” in order to detect publications relevant to 3D carotid ultrasonography. 
Publications in English language referring to clinical applications of 3D carotid ultrasonography and 
publications reporting 3D plaque volume measurement repeatability and/or reproducibility were 
retrieved as full text while review publications were excluded. Retrieved publications’ reference lists 
and abstracts were screened and additional relevant full text papers were also retrieved. 
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Results 
The query returned 512 records that were entered into the Abstract Screening flow chart in order 
to exclude irrelevant publications to the scope of this study (Figure 1).  In total, 191 records were 
deemed as relevant to 3D carotid ultrasonography and their count per publication year was cross-
tabulated by type of relevance (Figure 2) and by 3D imaging phenotype studied (Figure 3). It is clear 
that there is a growing publication interest during the past 15 years that focuses on imaging details 
research and specifically on volumetric measurements. Clinical applications of 3D ultrasonography also 
demonstrated an increase but to a lesser extent. Notably, computational fluid dynamics (CFD) 
applications based solely on 3DUS acquired volumes are commencing to be reported in the literature 
with results comparable with CFD based on Computed Tomography Angiography (CTA) or Magnetic 
Resonance Angiography (MRA) acquired volumes.37–41 
 
a. Clinical Relevance Studies 
Studies that investigated clinically relevant parameters of 3DUS and were able to be retrieved as 
full text were 54 and were used for qualitative analysis. They were subsequently grouped by the plaque 
parameter they reported on as follows: 
(1) Volume of the atherosclerotic plaque was the focus of interest of 32 studies, 18 of which 
investigated risk prediction potential of plaque volume (Table 1). Identification of atherosclerosis 
related genes was linked to plaque volume.42,43 Progression of different expressions of plaque volume 
(Total Plaque Volume – TPV, Vessel Wall Volume – VWV with or without the plaque) and plaque 
burden (Carotid Plaque Burden – CPB) were found to be predicted by diastolic blood pressure44, 
diabetes mellitus44–47, the male gender48 and absence of hormone replacement therapy in women49. In 
many cases46–48 IMT was deemed inferior compared to plaque volume with regards to risk prediction. 
Plaque volume phenotypes also had a predictive value on both the absence50 and severity of coronary 
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artery disease (CAD)51,52 and this effect was not detected for either IMT  or maximum plaque 
thickness.50 Furthermore, cardiovascular events rates were predicted by plaque volume53,54 and burden55 
progression and not by neither IMT nor Total Plaque Area (TPA). Finally, ex-smokers with non-clinical 
atherosclerosis were found to be carriers of larger (VWVs and TPVs) plaques compared to non-
smokers.56,57 
The remaining 14 studies employed plaque volume measurements to test treatment effects 
(Table 2). The concept of hypercholesterolemia effect on atherosclerosis was intuitively shown by 
Hennerici et al.31 in the first report of in-vivo TPV measurement by 3DUS. The authors demonstrated 
that TPV was reduced by extracorporeal plasmapheresis of hypercholesterolemic patients. After that, 
statin treatment effect was demonstrated in 6 more studies where authors proved that both TPV58,59 and 
VWV60–62 were reduced after statin treatment. Additionally, systolic blood pressure (SBP),63 
olmesatrtan64 and cilostazol65 were associated with plaque volume reduction while VWV rate of change 
was shown to be affected by Vitamin D supplement in patients with nephropathy.66 
(2) Stenosis degree measurement or categorization using 3DUS versus various different 
modalities was employed in 11 studies with multiple comparisons in many occasions (Table 3). DSA 
was used as the reference method in 5 studies where inter-method correlation (Spearman’s r) ranged 
from 0.5767 (p=0.01) to 0.82.34 The correlation was better when the area (vs diameter) method was 
used34 while it was noted that DSA underestimated medium grade (40-70%) stenoses.68 In 5 studies the 
reference method was 2DUS and the inter-method correlation (Spearman’s r) ranged from 0.83 
(p<0.001)69 to 0.99870. The correlation was found to be even better when Peak Systolic Velocity (PSV) 
was used (vs PSV Ratio)69 and when Power Doppler implementation was undertaken.70 When MRA 
was used as a reference method an IntraClass Correlation Coefficient (ICC) value of 0.79 +/- 0.17 was 
reported for grading ICA stenosis.71 Finally, Pfister et al.72 have elegantly compared surgical evaluation 
of carotid stenosis with a variety of modalities and demonstrated that MRA achieved an r=0.94 followed 
by 3D B-flow with contrast medium enhancement with an r=0.93. 
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(3) Surface features was the point of interest for 5 papers (Table 4) and the majority studied 
atherosclerotic plaque ulcers in terms of number and their change over time73,74, ability of detection75,76 
and ulcer volume.77 One publication reported that mobile plaque components were more readily 
identified by 3DUS compared to 2DUS.76 The main finds of the two largest cohorts were that (A)77 
ulcer volume >5mm3 and (B)74 presence of >3 ulcers/plaque together with detection of emboli on Trans 
Cranial Doppler (TCD) predicted cardiovascular events and revascularization procedures. 
(4) Texture of atherosclerotic plaques in three dimensions was analyzed in 7 studies (Table 
5). As a 3D GSM projection, Mean Gray Value (MGV) was calculated by Heliopoulos et al. and it was 
found to correlate with increased Vascular Endothelial Growth Factor (VEGF)78 serum levels as well as 
with symptomaticity79 of patients with carotid stenosis. Koyama et al.80 demonstrated that echogenic 
plaque areas without acoustic shadow corresponded to histology of macrophage infiltration and thus 
inflammatory activity (vulnerability) while the use of Integrated Back Scattering (IBS) in 3D associated 
increased lipid and blood plaque content with early symptomatic plaques.81 More recently, Awad et al.62 
and Engelen et al.54 developed models that accurately predicted vascular events and plaque response to 
aggressive statin therapy by incorporating changes in TPV together with changes in textural 
characteristics. 
 
b. Repeatability (IntraObserver Variability) and Reproducibility (InterObserver 
Variability) reporting Studies 
Studies that reported repeatability and reproducibility of 3DUS for plaque volume measurements 
that were able to be retrieved as full text were 33 and were used for comparative analysis since 
evaluation statistics varied significantly (Table 6). Mechanical Linear (ML) assemblies along with 
Manual Segmentation were used in more than half of the studies (n=17) and yielded an intraobserver 
variability that ranged from a coefficient of variance (COV)=3%44 to COV=23.9%82 and from 
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ICC=0.9147 to ICC=0.9583 while interobserver variability varied from COV=4%44 to COV=46.6%82 and 
from ICC=0.8283 to ICC=0.9342,43,46. Mechanical Rotation (MR) transducers results in conjunction with 
Manual Segmentation were reported in 6 studies. This combination gave an intraobserver variability that 
started from COV=3.1%84 and reached COV=4%85 and from ICC=0.9186 up to ICC=0.987.64 The 
respective interobserver variability reported was COV=6.4 +/- 4.1%85 and ranged from ICC=0.8786 to 
ICC=0.964.84 
Real Time (RT) 3DUS was utilized in 6 more recent studies and Manual Segmentation was also 
used for identifying anatomic features of the atherosclerotic plaque. In this case the intraobserver 
variability was as high as ICC=0.9452 to ICC=0.9965,87 while interobserver ICC was reported to be 
0.93.52 As far as registration is concerned, Graebe et al.86 compared ICCs for Untracked freehand 
(UFH) 3D Registration with those of an MR transducer and found that both intraobserver and 
interobserver variability were better for the MR system (0.91 vs 0.74 and 0.87 vs 0.6 respectively). 
Although semi-automated segmentation solutions were reported to significantly reduce the required time 
to complete the process, intraobserver variability was not improved.48,88 
Finally, 28 out of 33 studies used the TPV plaque phenotype to study volume measurement 
technique and progression. However, since 2007 Egger et al.82,83 introduced VWV (including plaque 
volume) and compared it with TPV reporting improved intraobserver (ICC=0.95 vs ICC=0.85) and 
interobserver (ICC=0.85 vs ICC=0.82) variability. 
 
Discussion 
Even though 3D carotid ultrasound has been around for the past 20 years and researchers are 
increasingly trying to prove that it can evolve carotid artery imaging, it is clear that its use has not been 
widely spread among clinicians. In order for two-dimensional carotid bifurcation images to be converted 
into reliable 3D information they have to be (A) Registered in space (3D Registration) and (B) Vessel, 
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lumen and plaque anatomic boundaries have to be recognized and properly marked for each and every 
2D image and then propagated into the 3rd dimension (Segmentation). The first researchers employed 
complicated and bulky linear stages31 and relevant software to complete image synthesis while more and 
more advanced technolohy has offered Real-Time 3D systems with either Mechanically rotated 
transducers or 2D-Arrays. Despite modern realizations being more practical, the cost remains a major 
limitation in widespread penetration of carotid 3DUS and the majority of researchers still use 
mechanical assemblies. Overall cumbersome registration and segmentation sequences involved with 
carotid 3DUS have rendered it unattractive to clinicians. 
This study demonstrates that plaque volume is the most valuable carotid atherosclerosis 
phenotype that 3DUS is offering to the clinician who is trying to prevent stroke and stabilize the 
atheromatous lesion. TPV dominates the literature and has been proven to be associated with 
atherosclerosis risk factors (arterial hypertension31, diabetes45, male gender48, smoking56) and to be 
adequately potent in predicting CAD phenotypes.50,52 More importantly, in contrast to IMT – a 
significant plaque phenotype used in large cross sectional studies for cardiovascular risk prediction – 
TPV change (regression or progression in 1 year) detection and measurement was recently found to be 
able to predict clinical cardiovascular events for the next 5 years.53,54 
Furthermore, Ainsworth et al.59 have proved that the regression effect of aggressive statin 
therapy on the volume of the atherosclerotic plaque as measured by TPV is so powerful that can be 
statistically detected even in small sample studies (20 patients) and in short time periods (3 months). A 
possibly important use of plaque volume measurements is in the clinical setting of monitoring an 
individual’s carotid plaque response to therapy. In this case, the minimum volume change that can be 
confidently detected beyond measurement variability depends on the desired confidence level and the 
operator variability.89 Landry et al.90,91 have published evidence on the effect of plaque size on TPV 
intraobserver and interobserver variability and noted that the volumetric change that must be observed to 
establish with 95% confidence that a plaque has undergone change was ≈20% to 35% for plaques <100 
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
16 
 
mm3 and ≈10% to 20% for plaques >100 mm3. Plaque volume measurement precision was unchanged 
for Inter Slide Distances (ISD) <3.0 mm, whereas plaque volume measurement variability increased 
with ISD. They demonstrated that both repeatability and reproducibility is increased for larger plaques 
making the method ideal for asymptomatic carotid disease fulfilling intervention criteria in terms of 
stenosis degree.17 For smaller plaques, the variability can be kept relatively low by lowering ISD as 
reported by Landry et al.56 
Variability has also been shown to decrease82,83 by the use of VWV which is a measure that 
contains both the plaque and a three dimensional representation of the IMT. When texture features are 
added to the algorithm62 along with surface characteristics like ulcer number74 and volume77, VWV can 
even more accurately detect plaque response to intervention (change) as well as predict cardiovascular 
events. Intuitively, the findings of ACSRS20 on Discrete White Areas without acoustic shadow are in 
accordance with Koyama et al.80 who related them with histology of macrophage plaque infiltration 
after 3DUS. 
  Real-time 3D systems are accompanied by excellent variability but are often hampered by 
increased costs while semi-automated segmentation realizations offer time saving but do not increase 
repeatability of reproducibility. Conceptually, a mechanical assembly kit that converts regular 2DUS 
systems into 3DUS realizations might be the solution to a more rapid and widespread adoption of 
3DUS. Electrocardiogram (ECG) Gated 3DUS71 was employed to minimize the effect of pulsation 
artefacts but it was not found to have significant effect for the study of atherosclerotic patients due to 
arterial rigidity. Carotid calcification has been shown to affect 3DUS due to acoustic shadowing but the 
use of multiple angle acquisitions (windows), contrast medium and b-Flow techniques can minimize this 
limitation.72 Finally, although 3DUS value in stenosis72 degree determination comes close to that of 
MRA when both compared to surgical evaluation, the method lacks the dynamic data of arch and 
cerebral circulation provided by DSA and MRA.  
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Conclusion 
In light of the improved efficacy of best medical therapy in reducing stroke risk associated with 
asymptomatic carotid disease the most recent AHA guidelines stated that the effectiveness of 
intervention for asymptomatic carotid disease compared to BMT is not well established. The present 
study has shown that 3DUS plaque volumetry is a repeatable and reproducible, non-invasive technique 
for monitoring the short-term progression or regression of asymptomatic carotid atherosclerosis in 
response to best medical treatment enhancement when a stenosis indication for intervention is set. 
Specially designed RCTs are in order to test whether 3DUS can improve identification of patients that 
benefit the most from asymptomatic carotid intervention. 
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Appendix A: Figures 
Figure 1: Literature Review flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3DUS=3D Ultrasonography, 2DUS=2D Color Ultrasonography, CFD=Computational 
Fluid Dynamics, CTA=Computed Tomography Angiography, 3DCTA=3D Computed 
Tomography Angiography, MRA=Magnetic Resonance Angiography, 3D4DMRA= 
3D/4D Magnetic Resonance Angiography, IVUS=Intra Vascular Ultrasound, 
3DIVUS=3D Intra Vascular Ultrasound, 3DTCD=3D Trans Cranial Doppler, 
DSA=Digital Subtraction Angiography, 3DDSA=Rotational Digital Subtraction 
Angiography, LTE=Letter to the Editor, LNG=Language 
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Figure 2: Stack chart of studies and their count per publication year is shown by type of relevance to 3D 
ultrasonography 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Stack chart of studies and their count per publication year is shown by plaque type phenotype 
investigated. (CFD=Cumputational Fluid Dynamics) 
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Appendix B: Tables 
Table 1 Clinical effect studied by 3D ultrasonography volumetry of the carotid bifurcation. 
 
 
Author Year 
Std 
Type 
Pts 
(n) 
Sx 
(%) 
Std 
Dur. 
(wk) 
3D 
Reg 
Conclusion 
1 
Delcker et 
al.44 
1995 CSS 54 0 12 
ML, 
ECG 
Diastolic blood pressure  (p<.01) and 
Diabetes (p<.03) independently predicted 
TPV progression 
2 
Griewing et 
al.49 
1999 CCS 90 6 18 
ML, 
ECG 
TPV progression greater in women without 
HRT versus with HRT. No significant 
changes in IMT 
3 
*Al-Shali et 
al.42 
2004 PC 161 n/r n/a ML 
Atherosclerosis linked gene PPARG c.1431T 
allele had greater TPV than others. Different 
allele associated with increased IMT 
4 
*Hegele et 
al.43 
2005 PC 150 n/r n/a ML 
Gluconeogenesis linked gene PCK1-232G/G 
genotype had more carotid IMT  but less 
TPV versus other genotypes 
5 
*Al-Shali et 
al.45 
2005 PC 168 n/r n/a ML 
Different ultrasound traits   showed different 
correlations with risk factors. (IMT to 
hypertension, TPA to smoking/cholesterol, 
TPV to diabetes) 
6 
*Pollex et 
al.46 
2005 CCS 98 n/r 84 ML 
TPV measurements (p=0.037), but not IMT, 
were higher in diabetics compared to the 
normoglycemic controls. 
7 
Riccio et 
al.47 
2006 PC 170 0 n/a ML 
only TPV (not IMT) was associated with 
diabetes and ulcerations in a diabetic 
population 
8 
Zhang et 
al.92 
2009 PC 104 55,7 n/a 
RT, 
ECG 
VCR and Systolic blood pressure were 
associated with ICEs independently. 
9 
Buchanan 
et al.48 
2012 PC 316 0 n/a TFH 
TPV, VWV, IMT associated with age in 
males. Only IMT associated in females. 
10 
Sillesen et 
al.51 
2012 PC 6101 0 n/a UFH CPB correlated stronger with CACS than IMT 
(Bioimage) 
11 Johri et al.50 2013 PC 70 0 n/a RT 
TPV predicted the absence of CAD better 
than max plaque thickness 
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12 Kim et al.52 2013 PC 107 0 n/a RT 
TPA and TPV showed correlation with CAD 
severity (not IMT) 
13 
Wannarong 
et al.53 
2013 PC 349 33,3 72 TFH 
TPV progression predicted cardiovascular 
events/death (not IMT, not TPA) 
14 Bedi et al.2 2014 PC 1422 0 n/a TFH 
Automatic Ultrasound increases subclinical 
Carotid disease detection rates. IMV included 
in FUN score 
15 
v. Engelen 
et al.54 
2014 PC 298 51,3 12 TFH 
Changes in plaque texture  and TPV  predict 
vascular events 
16 
**Pike et 
al.56 
2015 PC 61 0 n/a TFH 
Ex-smokers had significantly greater HeVDP 
and carotid TPV than never-smokers 
17 
Baber et 
al.55 
2015 PC 5808 0 36 UFH 
MACE rates increased with increasing CPB 
and CAC tertile (Bioimage) 
18 
**Cheng et 
al.57 
2016 PC 61 n/r n/a TFH 
Ex-smokers had significantly greater HeVDP 
and carotid VWV (and not VWV without 
plaque) than never-smokers 
 
Std: Study, Pts: Patients, Sx=Symptomatic, Dur=Duration, Reg=Registration, CSS=Cross Sectional Study, 
ML=Mechanical Linear Assembly, ECG=Electrocardiogram Gated, PC=Prospective Cohort, TPV=Total Plaque 
Volume, CCS=Case,Control Study, HRT=Hormone Replacement Therapy, IMT=Intima Media Thickness, 
n/r=Not reported, n/a=Not applicable, PPARG= Peroxisome proliferator-activated receptor gamma, PCK1= 
phosphoenolpyruvate carboxykinase 1, TPA=Total Plaque Area, RT=3D-RealTime, VCR=Volume Compression 
Ratio, ICE=Ischemic Cardiovascular event, TFH=Tracked FreeHand, VWV=Vessel Wall Volume, 
UFH=Untracked FreeHand, CPB=Carotid Plaque Burden, CACS=Coronary Artery Calcium Score, 
CAD=Coronary Artery Disease, IMV=Intima Media Volume, FUN=Fuster-Narula Score, HeVDP= (3)He 
ventilation defect percent, MACE=Major adverse cardiovascular events, CAC=Coronary Artery Calcification, * 
and ** Indicate substudies of the same patient cohort 
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Table 2: Clinical effect studied by 3D ultrasonography volumetry of the carotid bifurcation. 
 
 
Author 
 
Year 
Std 
Type 
Pts 
(n) 
Sx 
(%) 
Std 
Dur 
(wk) 
3D Reg Outcome 
1 
Hennerici et 
al.31 
1991 PC 21 14,2 17 ML 
TPV reduced in hypercholesterolemia by 
extracorporeal plasmapheresis 
2 Yao et al.34 1998 PC 20 100 n/a MR 
Vessel Volume increased after Patch CEA 
vs Primary closure 
3 
Schminkeet 
al.58 
2002 RT 31 69,5 21 ML 
TPV reduced by statin for echolucent 
plaques & dyslipidemic patients 
4 
*Ainsworth 
et al.59 
2005 RCT 38 0 3 ML 
TPV reduced by aggressive statin in 3 
months – Small sample adequate 
5 
Stumpe et 
al.64 
2007 RCT 165 0 24 ML 
TPV + IMT reduced by Olmesartan and not 
Atenolol (only IMT) 
6 
*Egger et 
al.60 
2008 RCT 8 0 3 ML VWV reduced by aggressive statin 
7 
Mallett et 
al.66 
2009 RCT 71 n/r 53 TFH 
VWV(cca+ica) rate of change affected by 
Vitamin B supplement in nephropathy (not 
TPA nor IMT) 
8 
*Krasinski 
et al.61 
2009 RCT 35 0 3 ML VWV reduced by aggressive statin 
9 
Yamada et 
al.93 
2009 RCT 40 0 6 
MR 
3DIBS 
Plaque Lipid volume decreased by statin vs 
lipid diet – Not volume 
10 Shai et al.63 2010 RCT 140 n/r 24 TFH 
Weight loss induced SBP reduction leads to 
decrease in VWV & IMT 
11 
*Awad et 
al.62 
2010 RCT 38 0 3 ML 
Texture features improve VWV sensitivity 
to detect plaque change after aggressive 
statin 
12 
Yamaguchi 
et al.65 
2012 PC 16 38,9 6 RT 
Cilostazol associated with  decreased TPV &  
increased GSM  - MRI reduced lipid 
components 
13 
Lindenmaier 
et al.94 
2013 RCT 39 100 6 ML 
Cardiac rehabilitation after TIA/Stroke does 
not alter IMT, TPV, VWV, TPA 
14 
Yamaguchi 
Oura et al.87 
2014 PC 16 61 12 RT 
Cilostazol associated ONLY with  MRI 
reduced lipid components in long term 
 
Std: Study, Pts: Patients, Sx=Symptomatic, Dur=Duration, Reg=Registration, PC=Prospective Cohort, 
ML=Mechanical Linear Assembly, TPV=Total Plaque Volume, MR=Mechanical Rotation Transducer, n/a=Not 
applicable, CEA=Carotid Endarterectomy, RT=Randomized Trial, RCT=Randomized  Controlled Trial, 
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IMT=Intima Media Thickness, VWV=Vessel Wall Volume, TFH=Tracked FreeHand, n/r=Not reported, 
CCA=Common Carotid Artery, ICA=Internal Carotid Artery, TPA=Total Plaque Area, 3DIBS=3D Integrated 
Back Scattering, RT=3D-RealTime, GSM=Gray Scale Median, MRI=Magnetic Resonance Imaging, 
TIA=Transient Ischemic Attack, *  Indicates substudies of the same patient cohort 
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Table 3: Stenosis degree studied by 3D ultrasonography of the carotid bifurcation compared to other   
modalities 
 
 
Author 
 
Year 
Pts 
(n) 
Sx 
% 
3D 
Reg 
Ref 
Inter-Method 
Evaluation 
Comment 
1 
Yao et 
al.34 
1998 20 100 UFH DSA 
r=0.82, 
MD=1.8±0.5% 
Area method is better than 
diameter. 
2 
Bendick 
et al.95 
1998 32 50 ML DSA 
Accuracy of 
87%. 
Categorization of stenosis 
degree 
3 
Keberle et 
al.70 
2000 75 48 
UFH 
PD 
2DUS 
r=0.982-0.998; 
p<0.01 
Power Doppler segmentation 
4 
Kozàkovà 
et al.68 
2001 46 69,5 
RT 
MR 
DSA 
r = 0.79, p<0.01; 
MD=7.8±15.5% 
For 40%-70%, 2DUS 
indicate a higher stenosis 
than DSA 
5 
Bucek et 
al.67 
2003 48 n/r 
TFH 
ECG 
2DUS r=0.85; P<0.001 
Excellent correlation with 
2DUS 
DSA r=0.57; P=0.01 
6 
Wessels et 
al.96 
2004 62 57,1 
TFH 
PD 
2DUS r=0.86; P<0.001 
3DUS tended to underestimate 
high-grade stenoses 
DSA r=0.74; P<0.001 
7 
Forsberg 
et al.69 
2008 59 n/r 
RT 
3DF 
PSV 
EDV 
ICC=0.83, 
p<0.0001 PSV was better than PSV 
Ratio 
PSVR ICC=0.65 
8 
Pfister et 
al.72 
2009 25 100 
RT 
MR 
SUR 
MRA r=0.94 
3D BFlow (+/- CM) compares 
with Surgical evaluation for 
Stenosis 
3D BFlow (+/- CM) better for 
Calcification 
 
3DBF+CM 
r=0.93 
3DBF r=0.91 
3DCCDS r=0.90 
CTA r=0.85 
3DPD r=0.84 
3DUS r=0.77 
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9 He et al.52 2013 66 0 
RT 
FTU 
MRA n/r 
Increased sensitivity to detect 
plaques reported 
10 
Pelz et 
al.71 
2015 73 16 TFH 
MRA 
CCA ICC 
0.67±0.19 
Not all plaques visualized due 
to calcification 
ICA ICC 
0.79±0.17 
2DUS 
ICC=0.8 
p<0.001 
11 
Igase et 
al.76 
2015 58 18,9 RT MRA n/r 
Mild stenoses not detected by 
MRA 
 
Std: Study, Pts: Patients, Sx=Symptomatic, Reg=Registration, Ref=Reference Method, UFH=Untracked 
FreeHand, DSA=Digital Subtraction Angiography, ML=Mechanical Linear Assembly, PD=Power Doppler, 
2DUS=2D Color Ultrasonography, r=Spearman’s Correlation Coefficient, RT=3D-RealTime, MR=Mechanical 
Rotation Transducer, n/r=Not reported, TFH=Tracked FreeHand, ECG=Electrocardiogram Gated, 3DUS=3D 
Ultrasonography , 3DF=3D Flow, PSV=Peak Systolic Velocity, EDV=End Diastolic Velocity, PSVR=Peak 
Systolic Velocity Ratio, ICC=Intraclass Correlation Coefficient, SUR=Surgery, MRA=Magnetic Resonance 
Angiography, 3DBF=3D B-Flow, CM=Contrast Medium, 3DCCDS=3D Color Coded Duplex Sonography, 
CTA=Computed Tomography Angiography, 3DPD=3D Power Doppler, FTU=Fly Through Ultrasound, 
CCA=Common Carotid Artery, ICA=Internal Carotid Artery 
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Table 4: Plaque Texture properties studied by 3D ultrasonography of the carotid bifurcation  
 
 
Author 
 
Year 
Study 
Type 
Pts 
(n) 
Sx 
(%) 
Study 
Duration 
(wk) 
3D Reg Outcome 
1 
Heliopoulos 
et al.78 
2004 PC 28 71,4 n/a UFH 
VEGF correlated to Plaque 
MGV (neovascularization) 
2 
Heliopoulos 
et al.79 
2008 PC 214 51,4 n/a UFH 
MGV lower in symptomatic 
patients with carotid stenosis 
3 
Faggioli et 
al.97 
2009 PC 68 0 n/a RT 
Detection of CAS stent 
intimal coverage associated 
with hypertension 
4 Awad et al.62 2010 RCT 38 n/r 3 ML 
Texture features improve VWV 
sensitivity to detect plaque 
change after aggressive statin 
5 
Yamada et 
al.81 
2011 RC 95 47,3 n/a 
RT 
3DIBS 
3D-IBS %Lipid & %Blood 
Plaque identified Early 
Symptomatic plaques 
6 
Koyama et 
al.80 
2013 PC 18 n/r n/a RT 
Macrophage infiltration 
associated with echogenic 
without acoustic shadow 
7 
Engelen et 
al.54 
2014 PC 298 51,3 12 TFH 
Changes in plaque texture  
and TPV  predict vascular 
events 
 
Pts: Patients, Sx=Symptomatic, wk=weeks, Reg=Registration, PC=Prospective Cohort, n/a=Not applicable, 
UFH=Untracked FreeHand, VEGF=Vascular Endothelial Growth Factor, MGV=Mean Gray Value, RT=3D-
RealTime, CAS=Carotid Artery Stenting, RCT=Randomized  Controlled Trial, ML=Mechanical Linear 
Assembly, n/r=Not reported, VWV=Vessel Wall Volume, 3DIBS=3D Integrated Back Scattering, TFH=Tracked 
FreeHand, TPV=Total Plaque Volume. 
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Table 5: Plaque Surface properties studied by 3D ultrasonography of the carotid bifurcation  
 
 
Author 
 
Year 
Study 
Type 
Pts 
(n) 
Sx 
(%) 
Study 
Duration 
(wk) 
3D Reg Outcome 
1 
Schminke et 
al.73 
2000 PC 17 75 24 ML 
Regression > Progression  
was observed for ulcers 
2 
Madani et 
al.74 
2011 PC 253 0 36 ML 
>3 Ulcers/plaque & TCD 
Emboli (+) had more events 
3 
Heliopoulos 
et al.75 
2011 PC 62 100 n/a UFH 
Ulcer Detection 3DUS > 
2DUS 
4 Kuk et al.77 2014 PC 313 66,8 60 RT 
Ulcer Volume >5mm predicts 
CVE & Revascularization 
5 Igase et al.76 2015 PC 58 18,9 n/a RT 
Moving plaques & Ulcers 
detected only by 3DUS 
 
Pts: Patients, Sx=Symptomatic, wk=weeks, Reg=Registration, PC=Prospective Cohort, ML=Mechanical Linear 
Assembly, TCD=Trans Cranial Doppler, UFH=Untracked FreeHand, 3DUS=3D Ultrasonography, 2DUS=2D 
Color Ultrasonography, RT=3D-RealTime, CVE=Cardiovascular Events. 
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Table 6: Repeatability (IntraObserver Variability) and Reproducibility (InterObserver Variability) 
reporting Studies 
 
 
Author 
 
Year 
Std 
Type 
Pts 
or 
Plq 
(n) 
Phen 
3D 
Reg 
Seg ECG 
Intra-Observer 
Evaluation 
Inter-Observer 
Evaluation 
1 
Hennerici 
et al. 31 
1991 PC 21 TPV ML MAN No COV 6% COV 18% 
2 
Delcker et 
al.44 
1995 PC 54 TPV ML MAN Yes COV 3% COV 4% 
3 
Griewing et 
al.98 
1997 PC 21 TPV ML MAN Yes COV 4.16% COV 5.7% 
4 Yao et al.34 1998 PC 20 VV MR MAN No 
SEE 42,9mm3 
r=0.99 N=20 
SEE 54,4mm3 
r=0.99 N=20 
5 
Delcker et 
al.99 
1998 PC 25 TPV TFH MAN 
Yes COV 4.6% COV 4.5% 
No COV 13.3% COV 16.7% 
6 
Palombo et 
al.85 
1998 PC 33 TPV MR MAN Yes 
COV 4+/-
2.7% 
COV 6.4+/-
4.1% 
7 
Griewing et 
al.49 
1999 
CC
S 
101 TPV ML MAN Yes ICC>0.85 
MEAN DIF 
<5% 
8 
Al-Shali et 
al.42 
2004 PC 161 TPV ML MAN No ICC=0.94 ICC=0.93 
9 
Landry et 
al.90 
2004 PC 40 TPV ML MAN No 
COV 19.2-
1.9% 
SEM=6.5% 
COV 24.1-
2.2% 
SEM=6.9% 
10 
Ainsworth 
et al.59 
2005 
RC
T 
38 TPV ML MAN No 53 mm3 n/r 
11 
Hegele et 
al.43 
2005 PC 150 TPV ML MAN No ICC=0.94 ICC=0.93 
12 
Pollex et 
al.46 
 
2005 
CC
S 
98 TPV ML MAN No ICC=0.94 ICC=0.93 
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13 
Landry et 
al.91 
2005 PC 48 TPV ML MAN No 
90.8-3.9% 
RMSD=4.2% 
70.2-3.1% 
RMSD=5.7% 
14 
Riccio et 
al.47 
2006 PC 170 TPV ML MAN No ICC=0.91 n/r 
15 
Stumpe et 
al.64 
2007 
RC
T 
165 TPV MR MAN No ICC=0.987 ICC=0.964 
16 
Egger et 
al.83 
2007 PC 10 
VWV ML MAN No 
4.6% 
ICC=0.95 
5.7% 
ICC=0.85 
TPV ML MAN No 
22.7% 
ICC=0.85 
31.1% 
ICC=0.82 
17 
Landry et 
al.89 
2007 PC 15 TPV ML MAN No RMSD=3.2% n/r 
18 
Ludwig et 
al. 84 
2008 PC 105 TPV MR MAN No 3.1-3.4% ICC=0.964 
19 
Egger et 
al.82 
2008 PC 10 
VWV ML MAN No COV 4.7% COV 13.5% 
TPV ML MAN No COV 23.9% COV 46.6% 
20 
Mallett et 
al.66 
2009 
RC
T 
71 VWV TFH MAN No COV 10% n/r 
21 
Zhang et 
al.92 
2009 PC 104 TPV RT MAN Yes 7.5% 8.3% 
22 
*Ukwatta 
et al.88 
2011 PC 21 VWV ML 
SEMI No 5.1% n/r 
MAN No 3.9% n/r 
23 
Yamaguchi 
et al.65 
2012 PC 16 TPV RT MAN No ICC=0.99 n/r 
24 
*Buchanan 
et al.48 
2012 PC 316 VWV TFH 
SEMI No 5.1% n/r 
MAN No 3.9% n/r 
25 
Sillesen et 
al.51 
2012 PC 
610
1 
TPV UFH SEMI No ICC=0.823 k=0.55 
26 
 
Kim et al.52 
 
2013 PC 107 TPV RT MAN No ICC=0.94 ICC=0.93 
27 
Johri et 
al.50 
2013 PC 70 TPV RT MAN No RMSE 7 mm3 k=0.912 
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28 
Cheng et 
al.100 
2013 PC 34 TPV ML 
MAN No 
COV 5.6-
7.85% 
n/r 
AUTO No n/r r=0.992-0.993 
29 
Yamaguchi 
Oura et 
al.87 
2014 PC 16 TPV RT MAN No ICC=0.99 n/r 
30 
Græbe et 
al.86 
2014 PC 62 TPV 
MR SEMI No ICC=0.91 ICC=0.87 
UFH SEMI No ICC 0.74 ICC 0.60 
31 Bar et al.101 2014 PC 20 TPV ML MAN Yes n/r r=0.808 
32 
Kalashyan 
et al.102 
2014 PC 82 TPV RT MAN No n/r 
COV 5.6+/- 
6% 
33 
AlMuhanna 
et al.103 
2015 PC 10 VWV MR MAN No 
ICC=0.95 
SEM=1.9% 
ICC=0.87 
SEM=4.7% 
 
Std: Study, Pts: Patients, Plq=Plaques, Phen=Imaging Phenotype, Dur=Duration, Reg=Registration, 
Seg=Segmentation, ECG=Electrocardiogram Gated, PC=Prospective Cohort, TPV=Total Plaque Volume, 
ML=Mechanical Linear Assembly, MAN=Manual, COV=Coefficient of variance, ICC=IntraClass Correlation 
Coefficient, VV=Vessel Volume, MR=Mechanical Rotation Transducer,  SEE=Standard Error of estimate, 
r=Spearman’s Correlation Coefficient, TFH=Tracked FreeHand, CCS=Case Control Study, SEM=Standard 
Error of Measurement, RCT=Randomized Controlled Trial, n/r=Not reported, RMSD=Root Mean Squared 
Difference, VWV=Vessel Wall Volume, RT=3D-RealTime, SEMI=Semi Automated, k=Cohen’s Kappa 
statistic, UFH=Untracked FreeHand, RMSE=Root Mean squared Error 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
31 
 
References 
 
1.  Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke 
statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):e2–
220.  
2.  Bedi R, Nagra A, Fukumoto T, Lynum S, Sengupta P, Aw J, et al. Detection of subclinical atherosclerosis in 
peripheral arterial beds with B-mode ultrasound: a proposal for guiding the decision for medical 
intervention and an artifact-corrected volumetric scoring index. Glob Heart. 2014 Dec;9(4):367–78.  
3.  de Weerd M, Greving JP, de Jong AWF, Buskens E, Bots ML. Prevalence of asymptomatic carotid artery 
stenosis according to age and sex: systematic review and metaregression analysis. Stroke J Cereb Circ. 2009 
Apr;40(4):1105–13.  
4.  Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, et al. The North American 
Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke J Cereb Circ. 1999 
Sep;30(9):1751–8.  
5.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC 
European Carotid Surgery Trial (ECST). Lancet. 1998 May 9;351(9113):1379–87.  
6.  Liapis CD, Bell PRF, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, et al. ESVS guidelines. 
Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc 
Surg. 2009 Apr;37(4 Suppl):1–19.  
7.  Kakisis JD, Avgerinos ED, Antonopoulos CN, Giannakopoulos TG, Moulakakis K, Liapis CD. The European 
Society for Vascular Surgery Guidelines for Carotid Intervention: An Updated Independent Assessment and 
Literature Review. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg [Internet]. 2012 May 31 [cited 2012 Jun 
9]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/22658616 
8.  Kartchner MM, McRae LP. Noninvasive evaluation and management of the “asymptomatic” carotid bruit. 
Surgery. 1977 Dec;82(6):840–7.  
9.  Thompson JE, Patman RD, Talkington CM. Asymptomatic carotid bruit: long term outcome of patients 
having endarterectomy compared with unoperated controls. Ann Surg. 1978 Sep;188(3):308–16.  
10.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic 
Carotid Atherosclerosis Study. JAMA J Am Med Assoc. 1995 May 10;273(18):1421–8.  
11.  Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by 
successful carotid endarterectomy in patients without recent neurological symptoms: randomised 
controlled trial. Lancet Lond Engl. 2004 May 8;363(9420):1491–502.  
12.  Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, et al. 10-year stroke prevention after 
successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. 
Lancet Lond Engl. 2010 Sep 25;376(9746):1074–84.  
13.  Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid 
stenosis: patients or professionals? Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2009 Jun;37(6):625–32.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
32 
 
14.  Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 
2012 Feb;9(2):116–24.  
15.  Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with 
asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke J Cereb Circ. 2009 
Oct;40(10):e573–83.  
16.  Naylor AR, Schroeder TV, Sillesen H. Clinical and imaging features associated with an increased risk of late 
stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2014 
Dec;48(6):633–40.  
17.  Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the 
primary prevention of stroke: a statement for healthcare professionals from the American Heart 
Association/American Stroke Association. Stroke J Cereb Circ. 2014 Dec;45(12):3754–832.  
18.  Giannakopoulos TG, Moulakakis K, Sfyroeras GS, Avgerinos ED, Antonopoulos CN, Kakisis JD, et al. 
Association between Plaque Echogenicity and Embolic Material Captured in Filter during Protected Carotid 
Angioplasty and Stenting. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2012 Jun;43(6):627–31.  
19.  Giannakopoulos TG, Antonopoulos CN, Moulakakis K, Sfyroeras GS, Kakisis JD, Brountzos EN, et al. Embolic 
material captured by filters during protected carotid artery stenting reflects plaque echogenicity: 
Implications for carotid stenting. Ital J Vasc Endovasc Surg. 2013;20(4):197–211.  
20.  Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, Sabetai M, Thomas DJ, et al. Asymptomatic internal carotid 
artery stenosis and cerebrovascular risk stratification. J Vasc Surg. 2010 Dec;52(6):1486–96.e1–5.  
21.  Kakkos SK, Nicolaides AN, Charalambous I, Thomas D, Giannopoulos A, Naylor AR, et al. Predictors and 
clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg. 2014 
Apr;59(4):956–67.e1.  
22.  Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Völzke H, Tuomainen T-P, et al. Carotid intima-media 
thickness progression to predict cardiovascular events in the general population (the PROG-IMT 
collaborative project): a meta-analysis of individual participant data. Lancet Lond Engl. 2012 Jun 
2;379(9831):2053–62.  
23.  Biasi GM, Froio A, Diethrich EB, Deleo G, Galimberti S, Mingazzini P, et al. Carotid plaque echolucency 
increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke 
(ICAROS) study. Circulation. 2004 Aug 10;110(6):756–62.  
24.  Kakkos SK, Griffin MB, Nicolaides AN, Kyriacou E, Sabetai MM, Tegos T, et al. The size of juxtaluminal 
hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J 
Vasc Surg. 2013 Mar;57(3):609–18.e1; discussion 617–8.  
25.  Singh N, Moody AR, Gladstone DJ, Leung G, Ravikumar R, Zhan J, et al. Moderate carotid artery stenosis: MR 
imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic 
men. Radiology. 2009 Aug;252(2):502–8.  
26.  Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. Association between carotid plaque characteristics 
and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke 
J Cereb Circ. 2006 Mar;37(3):818–23.  
27.  Underhill HR, Yuan C, Yarnykh VL, Chu B, Oikawa M, Dong L, et al. Predictors of surface disruption with MR 
imaging in asymptomatic carotid artery stenosis. AJNR Am J Neuroradiol. 2010 Mar;31(3):487–93.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
33 
 
28.  Moon SH, Cho YS, Noh TS, Choi JY, Kim B-T, Lee K-H. Carotid FDG Uptake Improves Prediction of Future 
Cardiovascular Events in Asymptomatic Individuals. JACC Cardiovasc Imaging. 2015 Aug;8(8):949–56.  
29.  Spence JD, Hegele RA. Noninvasive phenotypes of atherosclerosis: similar windows but different views. 
Stroke J Cereb Circ. 2004 Mar;35(3):649–53.  
30.  Blankenhorn DH, Chin HP, Strikwerda S, Bamberger J, Hestenes JD. Work in progress: common carotid 
artery contours reconstructed in three dimensions from parallel ultrasonic images. Radiology. 1983 
Aug;148(2):533–7.  
31.  Hennerici M, Kleophas W, Gries FA. Regression of carotid plaques during low density lipoprotein cholesterol 
elimination. Stroke J Cereb Circ. 1991 Aug;22(8):989–92.  
32.  Carvalho DDB, Klein S, Akkus Z, ten Kate GL, Schinkel AFL, Bosch JG, et al. Estimating 3D lumen centerlines of 
carotid arteries in free-hand acquisition ultrasound. Int J Comput Assist Radiol Surg. 2012 Mar;7(2):207–15.  
33.  Toonkum P, Suwanwela NC, Chinrungrueng C. Reconstruction of 3D ultrasound images based on Cyclic 
Regularized Savitzky-Golay filters. Ultrasonics. 2011 Feb;51(2):136–47.  
34.  Yao J, van Sambeek MR, Dall’Agata A, van Dijk LC, Kozakova M, Koudstaal PJ, et al. Three-dimensional 
ultrasound study of carotid arteries before and after endarterectomy; analysis of stenotic lesions and 
surgical impact on the vessel. Stroke J Cereb Circ. 1998 Oct;29(10):2026–31.  
35.  Chen Y, Nguyen M, Yen JT. 7.5 MHz dual-layer transducer array for 3-D rectilinear imaging. Ultrason 
Imaging. 2011 Jul;33(3):205–16.  
36.  Provost J, Papadacci C, Demene C, Gennisson J-L, Tanter M, Pernot M. 3-D ultrafast Doppler imaging applied 
to the noninvasive mapping of blood vessels in vivo. IEEE Trans Ultrason Ferroelectr Freq Control. 2015 
Aug;62(8):1467–72.  
37.  Glor FP, Ariff B, Hughes AD, Crowe LA, Verdonck PR, Barratt DC, et al. Image-based carotid flow 
reconstruction: a comparison between MRI and ultrasound. Physiol Meas. 2004 Dec;25(6):1495–509.  
38.  Glor FP, Ariff B, Hughes AD, Crowe LA, Verdonck PR, Barratt DC, et al. The integration of medical imaging 
and computational fluid dynamics for measuring wall shear stress in carotid arteries. Conf Proc Annu Int 
Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Annu Conf. 2004;2:1415–8.  
39.  Hammer S, Jeays A, Allan PL, Hose R, Barber D, Easson WJ, et al. Acquisition of 3-D arterial geometries and 
integration with computational fluid dynamics. Ultrasound Med Biol. 2009 Dec;35(12):2069–83.  
40.  Harrison GJ, How TV, Poole RJ, Brennan JA, Naik JB, Vallabhaneni SR, et al. Closure technique after carotid 
endarterectomy influences local hemodynamics. J Vasc Surg. 2014 Aug;60(2):418–27.  
41.  Sousa LC, Castro CF, António CC, Sousa F, Santos R, Castro P, et al. Computational simulation of carotid 
stenosis and flow dynamics based on patient ultrasound data - A new tool for risk assessment and surgical 
planning. Adv Med Sci. 2016 Mar;61(1):32–9.  
42.  Al-Shali KZ, House AA, Hanley AJG, Khan HMR, Harris SB, Zinman B, et al. Genetic variation in PPARG 
encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke 
J Cereb Circ. 2004 Sep;35(9):2036–40.  
43.  Hegele RA, Al-Shali KZ, House AA, Hanley AJG, Harris SB, Mamakeesick M, et al. Disparate associations of a 
functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke J Cereb Circ. 2005 
Dec;36(12):2566–70.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
34 
 
44.  Delcker A, Diener HC, Wilhelm H. Influence of vascular risk factors for atherosclerotic carotid artery plaque 
progression. Stroke J Cereb Circ. 1995 Nov;26(11):2016–22.  
45.  Al-Shali K, House AA, Hanley AJG, Khan HMR, Harris SB, Mamakeesick M, et al. Differences between carotid 
wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis. 
2005 Feb;178(2):319–25.  
46.  Pollex RL, Spence JD, House AA, Fenster A, Hanley AJG, Zinman B, et al. A comparison of ultrasound 
measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. 
Cardiovasc Ultrasound. 2005;3:15.  
47.  Riccio SA, House AA, Spence JD, Fenster A, Parraga G. Carotid ultrasound phenotypes in vulnerable 
populations. Cardiovasc Ultrasound. 2006;4:44.  
48.  Buchanan DN, Lindenmaier T, McKay S, Bureau Y, Hackam DG, Fenster A, et al. The relationship of carotid 
three-dimensional ultrasound vessel wall volume with age and sex: comparison to carotid intima-media 
thickness. Ultrasound Med Biol. 2012 Jul;38(7):1145–53.  
49.  Griewing B, Römer T, Spitzer C, Lüdemann J, Günther A, Kessler C. Hormone replacement therapy in 
postmenopausal women: carotid intima-media thickness and 3-D volumetric plaque quantification. 
Maturitas. 1999 May 31;32(1):33–40.  
50.  Johri AM, Chitty DW, Matangi M, Malik P, Mousavi P, Day A, et al. Can carotid bulb plaque assessment rule 
out significant coronary artery disease? A comparison of plaque quantification by two- and three-
dimensional ultrasound. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2013 Jan;26(1):86–95.  
51.  Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, et al. Carotid plaque burden as a 
measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the 
High Risk Plaque BioImage study. JACC Cardiovasc Imaging. 2012 Jul;5(7):681–9.  
52.  Kim HS, Cho KI. Association of carotid artery parameters of atherosclerosis in coronary artery disease. J 
Cardiovasc Ultrasound. 2013 Jun;21(2):72–80.  
53.  Wannarong T, Parraga G, Buchanan D, Fenster A, House AA, Hackam DG, et al. Progression of carotid plaque 
volume predicts cardiovascular events. Stroke J Cereb Circ. 2013 Jul;44(7):1859–65.  
54.  van Engelen A, Wannarong T, Parraga G, Niessen WJ, Fenster A, Spence JD, et al. Three-dimensional carotid 
ultrasound plaque texture predicts vascular events. Stroke J Cereb Circ. 2014 Sep;45(9):2695–701.  
55.  Baber U, Mehran R, Sartori S, Schoos MM, Sillesen H, Muntendam P, et al. Prevalence, impact, and 
predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the 
BioImage study. J Am Coll Cardiol. 2015 Mar 24;65(11):1065–74.  
56.  Pike D, Kirby M, Lindenmaier TJ, Sheikh K, Neron CE, Hackam DG, et al. Pulmonary abnormalities and carotid 
atherosclerosis in ex-smokers without airflow limitation. COPD. 2015 Feb;12(1):62–70.  
57.  Cheng J, Pike D, Chow TWS, Kirby M, Parraga G, Chiu B. Three-dimensional ultrasound measurements of 
carotid vessel wall and plaque thickness and their relationship with pulmonary abnormalities in ex-smokers 
without airflow limitation. Int J Cardiovasc Imaging. 2016 Jun 24;  
58.  Schminke U, Hilker L, Motsch L, Griewing B, Kessler C. Volumetric assessment of plaque progression with 3-
dimensional ultrasonography under statin therapy. J Neuroimaging Off J Am Soc Neuroimaging. 2002 
Jul;12(3):245–51.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
35 
 
59.  Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change 
in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke J Cereb Circ. 2005 
Sep;36(9):1904–9.  
60.  Egger M, Chiu B, Spence JD, Fenster A, Parraga G. Mapping spatial and temporal changes in carotid 
atherosclerosis from three-dimensional ultrasound images. Ultrasound Med Biol. 2008 Jan;34(1):64–72.  
61.  Krasinski A, Chiu B, Spence JD, Fenster A, Parraga G. Three-dimensional ultrasound quantification of 
intensive statin treatment of carotid atherosclerosis. Ultrasound Med Biol. 2009 Nov;35(11):1763–72.  
62.  Awad J, Krasinski A, Parraga G, Fenster A. Texture analysis of carotid artery atherosclerosis from three-
dimensional ultrasound images. Med Phys. 2010 Apr;37(4):1382–91.  
63.  Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, et al. Dietary intervention to reverse 
carotid atherosclerosis. Circulation. 2010 Mar 16;121(10):1200–8.  
64.  Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, et al. Carotid intima-media 
thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre 
Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007 
Dec;1(2):97–106.  
65.  Yamaguchi M, Sasaki M, Ohba H, Mori K, Narumi S, Katsura N, et al. Quantitative assessment of changes in 
carotid plaques during cilostazol administration using three-dimensional ultrasonography and non-gated 
magnetic resonance plaque imaging. Neuroradiology. 2012 Sep;54(9):939–45.  
66.  Mallett C, House AA, Spence JD, Fenster A, Parraga G. Longitudinal ultrasound evaluation of carotid 
atherosclerosis in one, two and three dimensions. Ultrasound Med Biol. 2009 Mar;35(3):367–75.  
67.  Bucek RA, Reiter M, Dirisamer A, Haumer M, Fritz A, Minar E, et al. Three-dimensional color Doppler 
sonography in carotid artery stenosis. AJNR Am J Neuroradiol. 2003 Aug;24(7):1294–9.  
68.  Kozàkovà M, Morizzo C, Andreucetti F, Palchetti P, Parenti G, Palombo C. Quantification of extracranial 
carotid artery stenosis by ultrafast three-dimensional ultrasound. J Am Soc Echocardiogr Off Publ Am Soc 
Echocardiogr. 2001 Dec;14(12):1203–11.  
69.  Forsberg F, Stein AD, Merton DA, Lipcan KJ, Herzog D, Parker L, et al. Carotid stenosis assessed with a 4-
dimensional semiautomated Doppler system. J Ultrasound Med Off J Am Inst Ultrasound Med. 2008 
Sep;27(9):1337–44.  
70.  Keberle M, Jenett M, Beissert M, Jahns R, Haerten R, Hahn D. Three-dimensional power Doppler sonography 
in screening for carotid artery disease. J Clin Ultrasound JCU. 2000 Dec;28(9):441–51.  
71.  Pelz JO, Weinreich A, Fritzsch D, Saur D. Quantification of Internal Carotid Artery Stenosis with 3D 
Ultrasound Angiography. Ultraschall Med Stuttg Ger 1980. 2015 Oct;36(5):487–93.  
72.  Pfister K, Rennert J, Greiner B, Jung W, Stehr A, Gössmann H, et al. Pre-surgical evaluation of ICA-stenosis 
using 3D power Doppler, 3D color coded Doppler sonography, 3D B-flow and contrast enhanced B-flow in 
correlation to CTA/MRA: first clinical results. Clin Hemorheol Microcirc. 2009;41(2):103–16.  
73.  Schminke U, Motsch L, Hilker L, Kessler C. Three-dimensional ultrasound observation of carotid artery 
plaque ulceration. Stroke J Cereb Circ. 2000 Jul;31(7):1651–5.  
74.  Madani A, Beletsky V, Tamayo A, Munoz C, Spence JD. High-risk asymptomatic carotid stenosis: ulceration 
on 3D ultrasound vs TCD microemboli. Neurology. 2011 Aug 23;77(8):744–50.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
36 
 
75.  Heliopoulos J, Vadikolias K, Piperidou C, Mitsias P. Detection of carotid artery plaque ulceration using 3-
dimensional ultrasound. J Neuroimaging Off J Am Soc Neuroimaging. 2011 Apr;21(2):126–31.  
76.  Igase K, Kumon Y, Matsubara I, Arai M, Goishi J, Watanabe H, et al. Utility of 3-dimensional ultrasound 
imaging to evaluate carotid artery stenosis: comparison with magnetic resonance angiography. J Stroke 
Cerebrovasc Dis Off J Natl Stroke Assoc. 2015 Jan;24(1):148–53.  
77.  Kuk M, Wannarong T, Beletsky V, Parraga G, Fenster A, Spence JD. Volume of carotid artery ulceration as a 
predictor of cardiovascular events. Stroke J Cereb Circ. 2014 May;45(5):1437–41.  
78.  Heliopoulos I, Papazoglou D, Piperidou H, Vadikolias K, Maltezos E, Artemis N. Carotid plaque 
echomorphology and serum vascular endothelial growth factor levels. Eur Neurol. 2004;51(2):104–8.  
79.  Heliopoulos J, Vadikolias K, Mitsias P, Artemis D, Tripsianis G, Piperidou C, et al. A three-dimensional 
ultrasonographic quantitative analysis of non-ulcerated carotid plaque morphology in symptomatic and 
asymptomatic carotid stenosis. Atherosclerosis. 2008 May;198(1):129–35.  
80.  Koyama S, Hashimoto T, Umahara T, Akai T, Watanabe D, Akimoto J, et al. Preoperative prediction of 
macrophage infiltration by 3-D tomographic ultrasound in endoarterectomized carotid plaques in elderly 
patients. Geriatr Gerontol Int. 2013 Oct;13(4):834–41.  
81.  Yamada K, Kawasaki M, Yoshimura S, Enomoto Y, Asano T, Minatoguchi S, et al. Evaluation of symptomatic 
carotid plaques by tissue characterization using integrated backscatter ultrasound and magnetic resonance 
imaging. Cerebrovasc Dis Basel Switz. 2011;31(3):305–12.  
82.  Egger M, Krasinski A, Rutt BK, Fenster A, Parraga G. Comparison of B-mode ultrasound, 3-dimensional 
ultrasound, and magnetic resonance imaging measurements of carotid atherosclerosis. J Ultrasound Med 
Off J Am Inst Ultrasound Med. 2008 Sep;27(9):1321–34.  
83.  Egger M, Spence JD, Fenster A, Parraga G. Validation of 3D ultrasound vessel wall volume: an imaging 
phenotype of carotid atherosclerosis. Ultrasound Med Biol. 2007 Jun;33(6):905–14.  
84.  Ludwig M, Zielinski T, Schremmer D, Stumpe KO. Reproducibility of 3-dimensional ultrasound readings of 
volume of carotid atherosclerotic plaque. Cardiovasc Ultrasound. 2008;6:42.  
85.  Palombo C, Kozakova M, Morizzo C, Andreuccetti F, Tondini A, Palchetti P, et al. Ultrafast three-dimensional 
ultrasound: application to carotid artery imaging. Stroke J Cereb Circ. 1998 Aug;29(8):1631–7.  
86.  Græbe M, Entrekin R, Collet-Billon A, Harrison G, Sillesen H. Reproducibility of two 3-D ultrasound carotid 
plaque quantification methods. Ultrasound Med Biol. 2014 Jul;40(7):1641–9.  
87.  Yamaguchi Oura M, Sasaki M, Ohba H, Narumi S, Oura K, Uwano I, et al. Carotid plaque characteristics on 
magnetic resonance plaque imaging following long-term cilostazol therapy. J Stroke Cerebrovasc Dis Off J 
Natl Stroke Assoc. 2014 Oct;23(9):2425–30.  
88.  Ukwatta E, Awad J, Ward AD, Buchanan D, Samarabandu J, Parraga G, et al. Three-dimensional ultrasound 
of carotid atherosclerosis: semiautomated segmentation using a level set-based method. Med Phys. 2011 
May;38(5):2479–93.  
89.  Landry A, Ainsworth C, Blake C, Spence JD, Fenster A. Manual planimetric measurement of carotid plaque 
volume using three-dimensional ultrasound imaging. Med Phys. 2007 Apr;34(4):1496–505.  
90.  Landry A, Spence JD, Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. 
Stroke J Cereb Circ. 2004 Apr;35(4):864–9.  
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
37 
 
91.  Landry A, Spence JD, Fenster A. Quantification of carotid plaque volume measurements using 3D ultrasound 
imaging. Ultrasound Med Biol. 2005 Jun;31(6):751–62.  
92.  Zhang PF, Su HJ, Yao GH, Wu W, Zhang M, Liu CX, et al. Plaque volume compression ratio, a novel 
biomechanical index, is independently associated with ischemic cerebrovascular events. J Hypertens. 2009 
Feb;27(2):348–56.  
93.  Yamada K, Yoshimura S, Kawasaki M, Enomoto Y, Asano T, Minatoguchi S, et al. Effects of atorvastatin on 
carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid 
atherosclerotic plaques with integrated backscatter ultrasound. Cerebrovasc Dis Basel Switz. 
2009;28(4):417–24.  
94.  Lindenmaier TJ, Buchanan DN, Pike D, Hartley T, Reid RD, Spence JD, et al. One, two and three-dimensional 
ultrasound measurements of carotid atherosclerosis before and after cardiac rehabilitation: preliminary 
results of a randomized controlled trial. Cardiovasc Ultrasound. 2013;11:39.  
95.  Bendick PJ, Brown OW, Hernandez D, Glover JL, Bove PG. Three-dimensional vascular imaging using Doppler 
ultrasound. Am J Surg. 1998 Aug;176(2):183–7.  
96.  Wessels T, Harrer JU, Stetter S, Mull M, Klötzsch C. Three-dimensional assessment of extracranial Doppler 
sonography in carotid artery stenosis compared with digital subtraction angiography. Stroke J Cereb Circ. 
2004 Aug;35(8):1847–51.  
97.  Faggioli GL, Ferri M, Serra C, Biagini E, Manzoli L, Lodi R, et al. The residual risk of cerebral embolism after 
carotid stenting: the complex interplay between stent coverage and aortic arch atherosclerosis. Eur J Vasc 
Endovasc Surg Off J Eur Soc Vasc Surg. 2009 May;37(5):519–24.  
98.  Griewing B, Schminke U, Morgenstern C, Walker ML, Kessler C. Three-dimensional ultrasound angiography 
(power mode) for the quantification of carotid artery atherosclerosis. J Neuroimaging Off J Am Soc 
Neuroimaging. 1997 Jan;7(1):40–5.  
99.  Delcker A, Tegeler C. Influence of ECG-triggered data acquisition on reliability for carotid plaque volume 
measurements with a magnetic sensor three-dimensional ultrasound system. Ultrasound Med Biol. 1998 
May;24(4):601–5.  
100.  Cheng J, Li H, Xiao F, Fenster A, Zhang X, He X, et al. Fully automatic plaque segmentation in 3-D carotid 
ultrasound images. Ultrasound Med Biol. 2013 Dec;39(12):2431–46.  
101.  Bar M, Roubec M, Farana R, Ličev L, Tomášková H, Školoudík D. Inter-rater reliability of carotid 
atherosclerotic plaque quantification by 3-dimensional sonography. J Ultrasound Med Off J Am Inst 
Ultrasound Med. 2014 Jul;33(7):1273–8.  
102.  Kalashyan H, Shuaib A, Gibson PH, Romanchuk H, Saqqur M, Khan K, et al. Single sweep three-
dimensional carotid ultrasound: reproducibility in plaque and artery volume measurements. 
Atherosclerosis. 2014 Feb;232(2):397–402.  
103.  AlMuhanna K, Hossain MM, Zhao L, Fischell J, Kowalewski G, Dux M, et al. Carotid plaque morphometric 
assessment with three-dimensional ultrasound imaging. J Vasc Surg. 2015 Mar;61(3):690–7.  
 
Institutional Repository - Library & Information Centre - University of Thessaly
05/02/2019 20:53:41 EET - 137.108.70.13
